Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Cell and Developmental Biology|August 29, 2022
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphomaSabrina Manni, Maria Pesavento, Zaira Spinello, et al.
Frontiers in Medicine|March 29, 2021
Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid TumorsMatteo Vassallo, Celine Michelangeli, Roxane Fabre, et al.
BMC Cancer|October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell deathFrancesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Journal of Clinical Medicine|August 27, 2021
Patients Admitted for Variant Alpha COVID-19 Have Poorer Outcomes than Those Infected with the Old StrainMatteo Vassallo, Sabrina Manni, Camille Klotz, et al.
Iscience|November 24, 2021
The long non-coding RNA <i>CDK6-AS1</i> overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamicsElena Porcù, Maddalena Benetton, Valeria Bisio, et al.
Discover Oncology|December 1, 2025
Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemiaNicolò Danesin, Giovanni Leone, Mattia D'Antiga, et al.
Oncotargets and Therapy|October 16, 2020
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic LeukemiaAndrea Visentin, Federica Frezzato, Filippo Severin, et al.
Blood Cancer Journal|February 15, 2018
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myelomaSara Canovas Nunes, Martina Manzoni, Marco Pizzi, et al.
Journal of Hematology & Oncology|November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicityLaura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Frontiers in Oncology|November 4, 2022
A bone-based 3D scaffold as an <i>in-vitro</i> model of microenvironment-DLBCL lymphoma cell interactionJessica Ceccato, Maria Piazza, Marco Pizzi, et al.
Pageof 5